Analyst Price Targets — R
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 6, 2026 12:07 pm | — | Morgan Stanley | $280.00 | $265.39 | TheFly | Ryder price target raised to $280 from $263 at Morgan Stanley |
| June 25, 2026 11:21 am | Brandon Oglenski | Barclays | $290.00 | $261.01 | TheFly | Ryder price target raised to $290 from $250 at Barclays |
| June 17, 2026 10:14 am | — | Robert W. Baird | $290.00 | $274.66 | TheFly | Ryder price target raised to $290 from $253 at Baird |
| June 5, 2026 10:30 am | Robert Salmon | Wells Fargo | $290.00 | $264.96 | TheFly | Ryder price target raised to $290 from $260 at Wells Fargo |
| April 24, 2026 11:12 am | Jordan Alliger | Goldman Sachs | $245.00 | $242.59 | TheFly | Ryder price target raised to $245 from $219 at Goldman Sachs |
| April 24, 2026 10:43 am | Daniel Moore | Robert W. Baird | $253.00 | $242.59 | TheFly | Ryder price target raised to $253 from $202 at Baird |
| April 24, 2026 9:37 am | — | Barclays | $250.00 | $242.59 | TheFly | Ryder price target raised to $250 from $220 at Barclays |
| February 13, 2026 3:04 pm | — | Goldman Sachs | $219.00 | $211.97 | TheFly | Ryder price target raised to $219 from $197 at Goldman Sachs |
| February 13, 2026 12:53 pm | Harrison Bauer | Susquehanna | $250.00 | $208.01 | TheFly | Ryder price target raised to $250 from $235 at Susquehanna |
| February 12, 2026 11:52 am | — | Wells Fargo | $236.00 | $217.31 | TheFly | Ryder price target raised to $236 from $210 at Wells Fargo |
Latest News for R
Ryder (R) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Five dividend growers recently raised payouts as resilient markets face inflation, trade and Fed risks, offering income-focused investors stocks to watch.
In this article series, I summarize dividend announcements of the past week. Eight dividend growth stocks announced increases, with PNC delivering the largest raise of 17.6%. MRSH stands out for high quality and a safe 37% payout ratio, while the stock trades 11% below fair value. FAST extended its 28-year dividend growth streak with an 8.3% increase but trades at a 13% premium to fair value.
Consistent efforts to reward its shareholders through dividend hikes highlight the financial strength of R.
BioLargo's newly formed subsidiary, BioLargo CPG, will bring to consumers the authentic, independently safety-tested CupriDyne® technology under its own brand following the marketing success of the original Pooph products that generated more than $125 million in pet-care sales while under license from BioLargo. WESTMINSTER, CA / ACCESS Newswire / July 13, 2026 / BioLargo, Inc. (OTCQX:BLGO) today announced that it is…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for R.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.